ThermoGenesis Holdings is a leading brand that offers a comprehensive range of solutions for automated clinical biobanking, COVID-19 testing, and large-scale cell processing for the CAR-T immunotherapy market. With a focus on advancing cell therapies and bioprocessing, ThermoGenesis has developed and commercialized innovative cell processing systems and devices for global researchers, biomanufacturing organizations, and clinicians. They specialize in providing highly efficient cell processing devices that deliver better outcomes in various applications in the cell and gene therapy field.

ThermoGenesis offers a variety of products and services, including automated cell processing systems like the AXP® II System, X-SERIES® X-LAB® System, X-WASH® System, and X-MINI® Selection Kit. They also provide clinical bio-banking solutions with their BioArchive® System, point-of-care solutions with the PXP®-SERIES, and cellular processing products such as the PXP®-1000 System and 3D Bag Set. With over 20 years of experience, ThermoGenesis is dedicated to advancing the field of cell therapy and providing researchers, clinicians, and biomanufacturers with cutting-edge solutions for their cell processing and storage needs